Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2020-02-14 Regulatory Filings
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure announces new US patent for Hexvix
Regulatory Filings Classification · 100% confidence The document is a press release from Photocure ASA dated February 14, 2020, announcing that the USPTO granted a new US patent (No. 10,556,010) covering the use of their product Hexvix. This announcement relates to securing intellectual property rights for research results and pipeline activities, which falls under general corporate news or regulatory updates rather than a specific financial report (like 10-K, ER, or IR). Since it is a specific announcement about a patent grant, it is not a general Regulatory Filing (RNS) but rather a specific corporate event announcement. However, none of the provided codes perfectly capture 'Patent Grant Announcement' or 'Intellectual Property Update'. Given the options, this type of announcement, which is a formal corporate disclosure but not a financial filing, often defaults to the most general regulatory/corporate announcement category, RNS, or potentially IP if that code is meant for IP-related news. Reviewing the definitions, 'IP' (Intellectual Property) is listed, and this document is explicitly about a patent grant. Therefore, 'IP' is the most appropriate classification.
2020-02-14 English
Financial calendar
Report Publication Announcement Classification · 98% confidence The document is titled 'Financial calendar' and lists scheduled dates for future corporate events like the 'Annual Report', 'Quarterly Report', and 'Annual General Meeting' for Photocure ASA. It is not the report itself, but an announcement detailing the schedule of future reports and meetings. Since there is no specific category for a 'Financial Calendar', and it is an announcement about future corporate events/filings, it best fits the general 'Regulatory Filings' fallback category (RNS), as it is a required disclosure under continuing obligations, although RPA is also a possibility if it were announcing the publication of this calendar itself. Given the content is purely a schedule, RNS is the most appropriate general regulatory disclosure fallback.
2020-01-30 English
Photocure ASA: Exercise of employee share options in Photocure ASA
Share Issue/Capital Change Classification · 95% confidence The document explicitly details the exercise of employee share options by primary insiders, leading to an increase in the company's share capital through the issuance of new shares. This action directly relates to changes in the company's share structure and capital. The most fitting category is 'Share Issue/Capital Change' (SHA), as it involves the issuance of new shares following option exercises. While 'Director's Dealing' (DIRS) is mentioned for primary insiders, the core event is the capital increase resulting from the option exercise, making SHA more precise for the overall corporate action described.
2019-12-31 English
Photocure ASA: Exercise of employee share options in Photocure ASA
Share Issue/Capital Change Classification · 95% confidence The document explicitly details the exercise of employee share options, resulting in the issuance of new shares and an increase in share capital. It also mentions transactions by primary insiders (executives). This activity directly relates to changes in the company's share structure and insider transactions. While it involves insiders (suggesting DIRS), the primary action is the capital change resulting from option exercise and subsequent share issuance. The closest fit among the provided definitions is 'Share Issue/Capital Change' (SHA) or potentially 'Director's Dealing' (DIRS) if focusing only on the insiders' actions. However, the core event is the capital increase due to option exercise. Since the document details the capital increase (issuing new shares) and the exercise mechanism, SHA is the most appropriate primary classification. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a report announcement (RPA) as it contains the substantive details.
2019-12-31 English
Photocure: Reduced recurrence after flexible Blue Light Cystoscopy with Hexvix® in surveillance ? New Publication of study results
Earnings Release Classification · 99% confidence The document is a press release from Photocure ASA, dated December 19, 2020, announcing that results from a study involving their product (Hexvix/Blue Light Cystoscopy) have been published in the journal 'Urology'. It details the study findings (reduced tumor recurrence) and provides context about bladder cancer. This is a typical announcement format for new scientific findings or clinical data releases, often preceding or accompanying a formal scientific publication. It is not a comprehensive annual report (10-K), an interim report (IR), a formal earnings release (ER), or a transcript (CT). Since it is an announcement about the publication of scientific results, it fits best under the general category of Investor/Regulatory Information. Given the content focuses on new data/results being made public, it is most closely aligned with an announcement of new information, but it is not a standard regulatory filing like a DIRS or MRQ. It is a press release announcing a publication. In the provided definitions, 'Regulatory Filings (RNS)' is the fallback for miscellaneous announcements. However, since it is a specific announcement about new data/results being made public, and it is not a formal financial report, 'Regulatory Filings (RNS)' serves as the most appropriate general category for non-standard corporate news releases that don't fit the other specific financial/governance codes. Q4 2020
2019-12-19 English
Photocure to present at the DNB Nordic Healthcare Conference in Oslo
Report Publication Announcement Classification · 99% confidence The document is a very short announcement (1020 characters) stating that PhotocureASA will be presenting at the DNB Nordic Healthcare Conference on December 12, 2019. It specifies the time, location, and presenter, and notes that the presentation will be posted online when held. This is not a full report (like 10-K or IR), nor is it a specific financial event like an earnings release (ER) or dividend announcement (DIV). It is an announcement about an upcoming investor event/presentation. Since there is no specific category for 'Presentation Announcement' other than the presentation material itself (IP), and this is merely an announcement *about* the presentation, it fits best under the general regulatory announcement category, RNS, as per the 'Menu vs Meal' rule suggesting short announcements often fall here if a more specific category isn't applicable, or potentially IP if we interpret it as a precursor to an Investor Presentation. However, given the text is purely logistical about *attending* a conference, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for this type of corporate event scheduling notice.
2019-12-06 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.